Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$22.0M
-33.4% from 2023
Prescriptions
2,104
$10,479.53 per claim
Patients
315
321 prescribers
Total spending, 2024
$22.0M
$69,996.59 per patient
Medicare prescription drug plans paid $22.0M for Zytiga in 2024, for 2,104 prescriptions and refills to 315 patients (down 33.4% from 2023). The average cost per claim was $10,479.53.
California had the highest Medicare cost for Zytiga in 2024: $3.2M for 294 claims, followed by New York ($3.0M).
Pooja R Patel, physician assistant in Charleston, SC, had the highest Medicare cost for Zytiga in 2024: 35 claims costing $361K.
Zytiga is made by Johnson & Johnson (JNJ), listed in the Medicare spending data as Janssen Pharm., Janssen Biotech.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Pooja R Patel Charleston, SC | Physician Assistant | 35 | Under 11 | $361K |
| Brian R Evans Florence, SC | Urology | 19 | Under 11 | $300K |
| Dania L Santiago-Caraballo |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 833 | 5,190 | 908 | $54.2M |
| 2023 | 529 | 3,134 | 560 | $33.1M |
| 2024 | 321 | 2,104 | 315 | $22.0M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 27 |
| Under 11 |
| $292K |
| Patrick Daily Jackson, MS | Urology | 26 | Under 11 | $288K |
| Arash Rezazadeh Kalebasty Orange, CA | Hematology-Oncology | 25 | Under 11 | $271K |
| Matthew R Zibelman Philadelphia, PA | Hematopoietic Cell Transplantation and Cellular Therapy | 28 | Under 11 | $254K |
| Zin W Myint Lexington, KY | Medical Oncology | 24 | Under 11 | $245K |
| Elliot M Paul New Hyde Park, NY | Urology | 15 | Under 11 | $209K |
| Thomas F Hogan Morgantown, WV | Medical Oncology | 18 | Under 11 | $200K |
| Monique A White Bronx, NY | Nurse Practitioner | 12 | Under 11 | $191K |
| Kenel Fernandes Barbosa Bayamon, PR | Hematology-Oncology | 17 | Under 11 | $183K |
| Abhishek Tripathi Duarte, CA | Medical Oncology | 16 | Under 11 | $171K |
| Curtis J Dunshee Tucson, AZ | Urology | 15 | Under 11 | $168K |
| Tamara L Musgrave Bristol, VA | Medical Oncology | 16 | Under 11 | $168K |
| Karen A Autio New York, NY | Medical Oncology | 15 | Under 11 | $165K |
| Tiffany Tomberlin New York, NY | Nurse Practitioner | 21 | Under 11 | $161K |
| Aaron D Berger Chicago Ridge, IL | Urology | 15 | Under 11 | $157K |
| Tessa A Chamberlain New York, NY | Nurse Practitioner | 15 | Under 11 | $156K |
| Mark G Delworth Jr. Blue Ash, OH | Urology | 14 | Under 11 | $154K |
| Jason L Rigdon Newnan, GA | Nurse Practitioner | 14 | Under 11 | $153K |
| Christopher M Pieczonka Syracuse, NY | Urology | 12 | Under 11 | $153K |
| Amit C Barochia Melbourne, FL | Hematology-Oncology | 13 | Under 11 | $152K |
| Herschel D Wallen Corvallis, OR | Medical Oncology | 15 | Under 11 | $151K |
| Debra J Zeroski Wheeling, WV | Nurse Practitioner | 13 | Under 11 | $148K |
| Gauri D Kelekar San Francisco, CA | Hematology-Oncology | 13 | Under 11 | $147K |
Spending by manufacturer as listed in the spending data